Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant - Related Studies

Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant (VICTA)

This study is currently recruiting participants.

Study NCT00078533. Last updated on May 7, 2008. Information provided by Baylor College of Medicine

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Stem Cell Transplantation
		Cytomegalovirus Infections

2	Additional conditions recognized in this trial
		Infection

3	More general conditions related to this trial
		DNA Virus Infections
		Herpesviridae Infections
		Virus Diseases

4	Interventions listed in this trial
		CMV CTL infusion

5	Sponsors listed in this trial
		Baylor College of Medicine
		The Methodist Hospital System
		Texas Children's Hospital
		Center for Cell and Gene Therapy